Relation of Endocrines and Clearing Factor Inhibitors to Hyperlipemia in Fasted Animals.
- 1 October 1956
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 93 (1) , 63-67
- https://doi.org/10.3181/00379727-93-22664
Abstract
A clearing factor inhibitor (IM) was apparently produced by the pituitary and induced hyperlipemia in animals primed for lipid mobilization. Intravenous injection of toxic doses of protamine sulfate, convulsant doses of diisopropylfluorophosphate (DFP) and pyrogenic doses of piromen produced hyperlipemia in intact animals. The same doses of these substances injected into adrenal-ectomized and hypophysectomized rats did not produce hyperlipemia. The hyperlipemic action of protamine or DFP was not attributable to direct inhibition of lipoprotein lipase but to a secondary effect mediated through the adrenals and pituitary. The hyperlipemic action of protamine, DFP, pyrogens and possibly other stressors was best explained by release of IM.Keywords
This publication has 7 references indexed in Scilit:
- Effect of Thyroxine and Related Compounds on Heparin-Activated Fatty Acid Liberating Enzyme.Experimental Biology and Medicine, 1955
- Lipemia Clearing by Hyaluronidase, Hyaluronate, and Deoxycorticosterone, and its Inhibition by Cortisone, Stress, and NephrosisExperimental Biology and Medicine, 1954
- In Vivo Effect of Anti-Heparin Agents on Serum Lipids and LipoproteinsAmerican Journal of Physiology-Legacy Content, 1954
- THE ENZYMATIC TRANSFORMATION OF LIPOPROTEINSJournal of Biological Chemistry, 1953
- Influence of Protamine on Alimentary LipemiaAmerican Journal of Physiology-Legacy Content, 1953
- Evidence for Lipolytic Action by Human Plasma Obtained after Intravenous Administration of Heparin.Experimental Biology and Medicine, 1953
- Cholic Acid: An Adequate Stimulus for Hypercholesteremia in the Normal Fasting Rat.Experimental Biology and Medicine, 1951